Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Abstract	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Authors	Karin Ribi, Weixiu Luo, Marco Colleoni, Per Karlsson, Jacquie Chirgwin, Stefan Aebi, Guy Jerusalem, Patrick Neven, Vincenzo Di Lauro, Henry L Gomez, Thomas Ruhstaller, Ehtesham Abdi, Laura Biganzoli, Bettina Müller, Annelore Barbeaux, Marie-Pascale Graas, Manuela Rabaglio, Prudence A Francis, Theodoros Foukakis, Olivia Pagani, Claudio Graiff, Daniel Vorobiof, Rudolf Maibach, Angelo Di Leo, Richard D Gelber, Aron Goldhirsch, Alan S Coates, Meredith M Regan, Jürg Bernhard, SOLE Investigators
Journal	British journal of cancer (Br J Cancer) Vol. 122 Issue 7 Pg. 1119 (Mar 2020) ISSN: 1532-1827 [Electronic] England
PMID	31949268 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!